{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:13:25Z","timestamp":1782980005689,"version":"3.54.5"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":118,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005423","name":"Uppsala University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010686","name":"Public Health Agency of Sweden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"ALF","doi-asserted-by":"publisher","award":["ALFGBG-965885"],"award-info":[{"award-number":["ALFGBG-965885"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An additional upsurge in bacterial STIs has been observed in Sweden following HIV pre-exposure prophylaxis (PrEP) implementation. From a prevention perspective, it is of relevance to optimize testing strategies within PrEP programmes to identify those most at risk. An open retrospective longitudinal observational cohort study was performed at three STI clinics in Uppsala, Gothenburg, and Malm\u00f6. A questionnaire and journal data regarding STI were collected from a sample of 199 MSM enrolled in the PrEP programmes and providing informed consent. Incident bacterial STIs during follow-up were analyzed with descriptive statistics, Poisson regression, and Cox regression. Median follow-up time was 632\u2009days. A total of 270 gonorrhoea or chlamydia infections were recorded during PrEP follow-up, compared to 194 cases in the 2-year period prior to enrolment, giving an incidence rate ratio (IRR) of 1.56 (CI 95% 1.30\u20131.89). The testing frequency increased by 75% (IRR 1.69, CI 95% 1.60\u20131.90). For diagnoses of active syphilis, the increase was 108% (IRR 2.08. CI 95% 1.04\u20134.06), compared with a 5-year period preceding enrolment. The hazard ratio of time (days) until a first STI after PrEP initiation was 2.87 (CI 95% 1.72\u20134.80) for those having had a STI prior to PrEP initiation and 2.06 (CI 95% 1.03\u20134.13) for those reporting experience of group sex in the past year compared with those who had not. STI prior to PrEP initiation and group sex were associated with STI after initiation of PrEP, factors that could be considered if needing prioritizing the frequency of STI screening.<\/jats:p>","DOI":"10.1093\/eurpub\/ckaf034","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:54:45Z","timestamp":1743882885000},"page":"752-759","source":"Crossref","is-referenced-by-count":1,"title":["Sexually transmitted infections among pre-exposure prophylaxis users in a Swedish multi-centre cohort"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-4031","authenticated-orcid":false,"given":"Tobias","family":"Herder","sequence":"first","affiliation":[{"name":"Social Medicine & Global Health, Department of Clinical Sciences, Faculty of Medicine, Lund University , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-0420","authenticated-orcid":false,"given":"Fredrik","family":"M\u00e5nsson","sequence":"additional","affiliation":[{"name":"Clinical Infection Medicine, Department of Translational Medicine, Faculty of Medicine, Lund University , Malm\u00f6,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sk\u00e5ne University Hospital , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8423-8566","authenticated-orcid":false,"given":"Petra","family":"Tunb\u00e4ck","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Gothenburg,","place":["Sweden"]},{"name":"Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland , Gothenburg,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7588-6407","authenticated-orcid":false,"given":"Karin","family":"Sanner","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Uppsala University Hospital , Region Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-1020","authenticated-orcid":false,"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland , Gothenburg,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Fridenstr\u00f6m","sequence":"additional","affiliation":[{"name":"Infection Medicine, Department of Medical Sciences, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0146-392X","authenticated-orcid":false,"given":"Minna","family":"Dawar","sequence":"additional","affiliation":[{"name":"Clinical Infection Medicine, Department of Translational Medicine, Faculty of Medicine, Lund University , Malm\u00f6,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sk\u00e5ne University Hospital , Malm\u00f6,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6706-0177","authenticated-orcid":false,"given":"Susanne","family":"Str\u00f6mdahl","sequence":"additional","affiliation":[{"name":"Infection Medicine, Department of Medical Sciences, Uppsala University , Uppsala,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Uppsala University Hospital , Region Uppsala,","place":["Sweden"]},{"name":"Global and Sexual Health, Department of Global Public Health, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"2025073115054820800_ckaf034-B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2025073115054820800_ckaf034-B2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2025073115054820800_ckaf034-B3","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2025073115054820800_ckaf034-B4","author":"WHO","year":"2014"},{"key":"2025073115054820800_ckaf034-B5","author":"RAV","year":"2017"},{"key":"2025073115054820800_ckaf034-B6","author":"RFSL","year":"2024"},{"key":"2025073115054820800_ckaf034-B7","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"Murchu","year":"2022","journal-title":"BMJ Open"},{"key":"2025073115054820800_ckaf034-B8","doi-asserted-by":"publisher","first-page":"2300451","DOI":"10.2807\/1560-7917.ES.2024.29.13.2300451","article-title":"Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022","volume":"29","author":"von Schreeb","year":"2024","journal-title":"Euro Surveill"},{"key":"2025073115054820800_ckaf034-B9","doi-asserted-by":"publisher","first-page":"e2031102","DOI":"10.1001\/jamanetworkopen.2020.31102","article-title":"Preventing disease, not sex-harm reduction, HIV preexposure prophylaxis, and sexually transmitted infections","volume":"3","author":"Stewart","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025073115054820800_ckaf034-B10","doi-asserted-by":"publisher","first-page":"e0269688","DOI":"10.1371\/journal.pone.0269688","article-title":"Beyond HIV prevention: additional individual and community-level benefits of PrEP among Latino gay and bisexual men","volume":"17","author":"Brooks","year":"2022","journal-title":"PLoS One"},{"key":"2025073115054820800_ckaf034-B11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/sextrans-2022-055455","article-title":"Sexual transmission of infections across Europe: appraising the present, scoping the future","volume":"98","author":"Geretti","year":"2022","journal-title":"Sex Transm Infect"},{"key":"2025073115054820800_ckaf034-B12","doi-asserted-by":"publisher","first-page":"e0248582","DOI":"10.1371\/journal.pone.0248582","article-title":"Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to re-evaluate STI-screening as a control strategy?","volume":"16","author":"Marcus","year":"2021","journal-title":"PLoS One"},{"key":"2025073115054820800_ckaf034-B13","author":"Dawar","year":"2022"},{"key":"2025073115054820800_ckaf034-B14","author":"RAV","year":"2023"},{"key":"2025073115054820800_ckaf034-B15","author":"eH\u00e4lsomyndigheten"},{"key":"2025073115054820800_ckaf034-B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for syphilis testing, United States, 2024","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2025073115054820800_ckaf034-B17","doi-asserted-by":"publisher","first-page":"s43","DOI":"10.1093\/cid\/ciaa307","article-title":"The traditional or reverse algorithm for diagnosis of syphilis: pros and cons","volume":"71","author":"Ortiz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025073115054820800_ckaf034-B18","doi-asserted-by":"publisher","first-page":"e2030806","DOI":"10.1001\/jamanetworkopen.2020.30806","article-title":"Comparison of trends in rates of sexually transmitted infections before vs after initiation of HIV preexposure prophylaxis among men who have sex with men","volume":"3","author":"McManus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025073115054820800_ckaf034-B19","author":"Public Health Agency of Sweden","year":"2023"},{"key":"2025073115054820800_ckaf034-B20","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/QAD.0000000000003187","article-title":"Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis","volume":"36","author":"Zeggagh","year":"2022","journal-title":"AIDS"},{"key":"2025073115054820800_ckaf034-B21","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2352-3018(19)30136-5","article-title":"Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study","volume":"6","author":"Hoornenborg","year":"2019","journal-title":"Lancet HIV"},{"key":"2025073115054820800_ckaf034-B22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","article-title":"Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis","volume":"67","author":"Traeger","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025073115054820800_ckaf034-B23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jama.2019.2947","article-title":"Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection","volume":"321","author":"Traeger","year":"2019","journal-title":"JAMA"},{"key":"2025073115054820800_ckaf034-B24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/sextrans-2022-055439","article-title":"Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study","volume":"99","author":"Jongen","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025073115054820800_ckaf034-B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/sextrans-2024-056165","article-title":"Primum non-nocere: is it time to stop screening for Neisseria gonorrhoeae and Chlamydia trachomatis in men who have sex with men taking HIV pre-exposure prophylaxis?","volume":"100","author":"Vanbaelen","year":"2024","journal-title":"Sex Transm Infect"},{"key":"2025073115054820800_ckaf034-B26","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/s2352-3018(23)00299-0","article-title":"Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial","volume":"11","author":"Vanbaelen","year":"2024","journal-title":"Lancet HIV"},{"key":"2025073115054820800_ckaf034-B27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1353\/ken.2021.0026","article-title":"Contextualizing risk in the ethics of PrEP as HIV prevention: the lived experiences of MSM","volume":"31","author":"Montess","year":"2021","journal-title":"Kennedy Inst Ethics J"},{"key":"2025073115054820800_ckaf034-B28","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s11135-011-9640-9","article-title":"Determinants of social desirability bias in sensitive surveys: a literature review","volume":"47","author":"Krumpal","year":"2013","journal-title":"Qual Quant"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/35\/4\/752\/62874243\/ckaf034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/35\/4\/752\/62874243\/ckaf034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:05:54Z","timestamp":1753988754000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/35\/4\/752\/8106773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,4]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckaf034","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"value":"1101-1262","type":"print"},{"value":"1464-360X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,4]]}}}